Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).

× No keyword cloud information.

49 in total

1. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

Authors: D F Martin; B D Kuppermann; R A Wolitz; A G Palestine; H Li; C A Robinson
Journal: N Engl J Med Date: 1999-04-08 Impact factor: 91.245

2. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors: D S McKinsey; L J Wheat; G A Cloud; M Pierce; J R Black; D M Bamberger; M Goldman; C J Thomas; H M Gutsch; B Moskovitz; W E Dismukes; C A Kauffman
Journal: Clin Infect Dis Date: 1999-05 Impact factor: 9.079

3. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.

Authors: B Dannemann; J A McCutchan; D Israelski; D Antoniskis; C Leport; B Luft; J Nussbaum; N Clumeck; P Morlat; J Chiu
Journal: Ann Intern Med Date: 1992-01-01 Impact factor: 25.391

4. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.

Authors: G J Weverling; A Mocroft; B Ledergerber; O Kirk; J Gonzáles-Lahoz; A d'Arminio Monforte; R Proenca; A N Phillips; J D Lundgren; P Reiss
Journal: Lancet Date: 1999-04-17 Impact factor: 79.321

5. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Authors: S J Goldie; K M Kuntz; M C Weinstein; K A Freedberg; M L Welton; J M Palefsky
Journal: JAMA Date: 1999-05-19 Impact factor: 56.272

6. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.

Authors: A Carr; B Tindall; B J Brew; D J Marriott; J L Harkness; R Penny; D A Cooper
Journal: Ann Intern Med Date: 1992-07-15 Impact factor: 25.391

7. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.

Authors: A G Palestine; M A Polis; M D De Smet; B F Baird; J Falloon; J A Kovacs; R T Davey; J J Zurlo; K M Zunich; M Davis
Journal: Ann Intern Med Date: 1991-11-01 Impact factor: 25.391

8. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy.

Authors: M M Schneider; J C Borleffs; R P Stolk; C A Jaspers; A I Hoepelman
Journal: Lancet Date: 1999-01-16 Impact factor: 79.321

9. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.

Authors: M M Schneider; A I Hoepelman; J K Eeftinck Schattenkerk; T L Nielsen; Y van der Graaf; J P Frissen; I M van der Ende; A F Kolsters; J C Borleffs
Journal: N Engl J Med Date: 1992-12-24 Impact factor: 91.245

10. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.

Authors: W D Hardy; J Feinberg; D M Finkelstein; M E Power; W He; C Kaczka; P T Frame; M Holmes; H Waskin; R J Fass
Journal: N Engl J Med Date: 1992-12-24 Impact factor: 91.245